POLYMEDNSEPoly Medicure Limited· PharmaceuticalsHighNeutral
Announced Tue, 23 Sept · 20:39 IST

Completion of Acquisition: RisoR Holdings B.V., Amsterdam, Netherlands, a wholly-owned step-down subsidiary of the Company, has completed the acquisition of Pendracare Holdings B.V. and Wellinq Medical B.V., Amsterdam, Netherlands ( PendraCare Group ).

Listed Co AcquisitionStrategic Transactions View source PDF

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Poly Medicure Limited has completed the acquisition of the PendraCare Group — consisting of Pendracare Holdings B.V. and Wellinq Medical B.V., both based in Amsterdam, Netherlands. The deal was executed through its wholly-owned step-down Dutch subsidiary, RisoR Holdings B.V., after a Share Purchase Agreement was signed on September 23, 2025. Post-completion, Poly Medicure holds 90% of economic rights in the PendraCare Group, making both entities step-down subsidiaries of the company. The acquisition was first approved at the Board Meeting on September 3, 2025, and all conditions under the SPA have now been fulfilled.

Likely market impact

This closes a key international acquisition, giving Poly Medicure a stronger foothold in the European medical devices market. While near-term integration costs may apply, shareholders can expect broader product reach and revenue diversification. The deal removes execution uncertainty and is a positive signal of the company's inorganic growth strategy.